(Q38399184)

2 September 2017

title

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

2 September 2017

main subject

1 reference

1 reference

Frank C Sciurba

39

0 references

Joan B. Soriano

Joan B Soriano

43

0 references

David M. Mannino

David M Mannino

32

0 references

Alberto A Papi

Alberto Papi

36

0 references

Nicolas Roche

Nicolas Roche

38

0 references

William MacNee

William MacNee

7

0 references

Marc Miravitlles

Marc Miravitlles

34

0 references

Enrico M. Clini

Enrico M Clini

18

0 references

Leonardo M. Fabbri

Leonardo M Fabbri

22

0 references

Thierry Troosters

46

Thierry Troosters

1 reference

2 September 2017

2

Marc Decramer

1 reference

2 September 2017

12

Antonio Anzueto

1 reference

2 September 2017

11

Claus Vogelmeier

1 reference

2 September 2017

53

Emiel F M Wouters

1 reference

2 September 2017

33

Fernando J Martinez

1 reference

2 September 2017

27

Maurice Hayot

1 reference

2 September 2017

21

Daniel J Dusser

1 reference

2 September 2017

41

Nikos Siafakas

1 reference

2 September 2017

40

Sanjay Sethi

1 reference

2 September 2017

1

Bartolome R Celli

1 reference

2 September 2017

3

Jadwiga A Wedzicha

1 reference

2 September 2017

6

Gerard J Criner

1 reference

2 September 2017

8

Barry J Make

1 reference

2 September 2017

15

Pierre-Regis Burgel

1 reference

2 September 2017

16

Peter M Calverley

1 reference

2 September 2017

17

Ciro Casanova

1 reference

2 September 2017

20

Harvey O Coxson

1 reference

2 September 2017

23

Bonnie Fahy

1 reference

2 September 2017

24

Gary T Ferguson

1 reference

2 September 2017

26

Monica J Fletcher

1 reference

2 September 2017

35

Paula M Meek

1 reference

2 September 2017

42

Don D Sin

1 reference

2 September 2017

44

James K Stoller

1 reference

2 September 2017

47

Geert M Verleden

1 reference

2 September 2017

48

Johny Verschakelen

1 reference

2 September 2017

49

Jorgen Vestbo

1 reference

2 September 2017

51

George R Washko

1 reference

2 September 2017

54

Richard L ZuWallack

1 reference

ATS/ERS Task Force for COPD Research

2 September 2017

55

ATS/ERS Task Force for COPD Research

1 reference

2 September 2017

Kevin C Wilson

4

1 reference

2 September 2017

Alvar Agustí

5

1 reference

2 September 2017

Stephen I Rennard

9

1 reference

2 September 2017

Robert A Stockley

10

1 reference

2 September 2017

David H Au

13

1 reference

2 September 2017

Peter J Barnes

14

1 reference

2 September 2017

Christopher B Cooper

19

1 reference

2 September 2017

Andrew Fisher

25

1 reference

2 September 2017

John R Hurst

28

1 reference

2 September 2017

Paul W Jones

29

1 reference

2 September 2017

Donald A Mahler

30

1 reference

2 September 2017

François Maltais

31

1 reference

2 September 2017

Klaus F Rabe

37

1 reference

2 September 2017

Donald P Tashkin

45

1 reference

2 September 2017

John W Walsh

50

1 reference

2 September 2017

Robert A Wise

52

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

2 September 2017

published in

1 reference

2 September 2017

volume

191

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

e4-e27

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Measuring the global burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

50-year trends in smoking-related mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: a primary care survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Validation and comparison of reference equations for the 6-min walk distance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Quantitative assessment of the airway wall using computed tomography and optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Thin-section CT in obstructive pulmonary disease: discriminatory value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

New and current clinical imaging techniques to study chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Accuracy of low-dose computed tomography (CT) for detecting and characterizing the most common CT-patterns of pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Population impact of different definitions of airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Patient-reported dyspnea in COPD reliability and association with stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Multicomponent indices to predict survival in COPD: the COCOMICS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The human phenome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Ageing and multimorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Network medicine, multimorbidity and the lung in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Ageing and the epidemiology of multimorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Increased risk of myocardial infarction and stroke following exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Prediction of acute respiratory disease in current and former smokers with and without COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Oxidative Stress in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The lung microbiome in moderate and severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Immunologic aspects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Cigarette smoke and CFTR: implications in the pathogenesis of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Inflammation and repair processes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Global effects of smoking, of quitting, and of taxing tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Smoking and lung function of Lung Health Study participants after 11 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Smokers with airway obstruction are more likely to quit smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy of confronting smokers with airflow limitation for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Updated US smoking cessation guideline advises counseling, combining therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Systematic review and meta-analysis of combination therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect of varying levels of disease management on smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Electronic nicotine delivery systems: a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Electronic cigarettes. A position statement of the forum of international respiratory societies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Harm reduction--a treatment approach for resistant smokers with tobacco-related symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Does smoking reduction increase future cessation and decrease disease risk? A qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Tiotropium might improve survival in subjects with COPD at high risk of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The role of bronchodilator treatment in the prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Reported pneumonia in patients with COPD: findings from the INSPIRE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Development and first validation of the COPD Assessment Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Adherence to inhaled therapy, mortality and hospital admission in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Inhaler mishandling remains common in real life and is associated with reduced disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

What the pulmonary specialist should know about the new inhalation therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

New anti-inflammatory targets for chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

New insights into the immunology of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Glucocorticoid resistance in inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Macrolide effects on the prevention of COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Azithromycin for prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Azithromycin and the risk of cardiovascular death

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Use of azithromycin and death from cardiovascular causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Statins and outcome after hospitalization for COPD exacerbation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Statins in COPD: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Associations between statins and COPD: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Systemic manifestations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Continuous oxygen therapy in chronic airway obstruction. Observations on possible oxygen toxicity and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Review of burn injuries secondary to home oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Non-invasive ventilation in acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A randomized study of endobronchial valves for advanced emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Assessing the benefit of accepting a single lung offer now compared with waiting for a subsequent double lung offer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

The pathophysiology of cachexia in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Nutritional support for individuals with COPD: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Physical activity, nutritional status and systemic inflammation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Diet and vitamin D as risk factors for lung impairment and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of an integrated care intervention on risk factors of COPD readmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Telemedicine-assisted home support for patients with advanced chronic obstructive pulmonary disease: preliminary results after nine-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effects of home telemonitoring to support improved care for chronic obstructive pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Patient-physician communication about end-of-life care for patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A randomized trial to improve communication about end-of-life care among patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Barriers to advance care planning in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Patient-clinician communication about end-of-life care for Dutch and US patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Gui

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

BTS guidelines: guidelines on the selection of patients with lung cancer for surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Preoperative considerations for patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Relationship of Carbon Monoxide Pulmonary Diffusing Capacity to Postoperative Cardiopulmonary Complications in Patients Undergoing Pneumonectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Preoperative assessment as a predictor of mortality and morbidity after lung resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

High prevalence of respiratory symptoms during air travel in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Short- and Medium-term Prognosis in Patients Hospitalized for COPD Exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Determinants of the Survival Benefit of Lung Transplantation in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Performance at Symptom-Limited Stair-Climbing Test is Associated With Increased Cardiopulmonary Complications, Mortality, and Costs After Major Lung Resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Predictors of early morbidity after major lung resection in patients with and without airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and Hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

Lungs, Bone Marrow, and Adipose Tissue. A Network Approach to the Pathobiology of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0044ST

10.1164/RCCM.201501-0044ST

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference